Sarepta Therapeutics (SRPT) FCF Margin Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 41,916.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41,916.00 |
| Dec 31, 2025 | 2,062.00 |
| Sep 30, 2025 | 1,371.00 |
| Jun 30, 2025 | 4,148.00 |
| Mar 31, 2025 | -40,392.00 |
| Dec 31, 2024 | 2,409.00 |
| Sep 30, 2024 | 2,040.00 |
| Jun 30, 2024 | 62,594.00 |
| Mar 31, 2024 | 1,995.00 |
| Dec 31, 2023 | 4,342.00 |
| Sep 30, 2023 | -828.00 |
| Jun 30, 2023 | -59,392.00 |
| Mar 31, 2023 | 39,866.00 |
| Dec 31, 2022 | -3,116.00 |
| Sep 30, 2022 | 3,529.00 |
| Jun 30, 2022 | 4,517.00 |
| Mar 31, 2022 | -34,786.00 |
| Dec 31, 2021 | 87,495.00 |
| Sep 30, 2021 | 110,080.00 |
| Jun 30, 2021 | 40,612.00 |
| Mar 31, 2021 | -481,483.00 |
| Dec 31, 2020 | -72,226.00 |
| Sep 30, 2020 | -109,372.00 |
| Jun 30, 2020 | -38,615.00 |
| Mar 31, 2020 | 486,443.00 |
| Dec 31, 2019 | -1,189.00 |
| Sep 30, 2019 | 9,237.00 |
| Jun 30, 2019 | 7,022.00 |
| Mar 31, 2019 | -11,271.00 |
| Dec 31, 2018 | -10,792.00 |
| Sep 30, 2018 | -4,231.00 |
| Jun 30, 2018 | 8,011.00 |
| Mar 31, 2018 | 30,751.00 |
| Dec 31, 2014 | -10.52 Mn |
| Sep 30, 2014 | -400,352.00 |
| Jun 30, 2014 | -128,304.00 |
| Mar 31, 2014 | -21,644.00 |
| Dec 31, 2013 | -60,425.00 |
| Sep 30, 2013 | -40,617.00 |
| Jun 30, 2013 | -36,925.00 |
| Mar 31, 2013 | -25,453.00 |